Market Overview:
The global DNA molecular weight marker market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The market growth is attributed to the increasing demand for PCR, sequencing, and other applications in research and clinical laboratories. In addition, the growing demand for high-quality products is also fueling the growth of this market. Based on type, the global DNA molecular weight marker market can be segmented into below 50 base-pair (bp), 50 bp to 100 bp, 100 bp to 1 kilo base-pair (kb), 1 kb to 5 kb, and above 5 kb segments. The below 50 base-pair (bp) segment accounted for the largest share of the global DNA molecular weight marker market in 2017 owing to its low cost and easy availability. However, this segment is projected to lose its share by 2030 due To Increasing preference For High Molecular Weight Markers over Low Molecular Weight Markers By Researchers And Clinicians. Based on application, the global DNA molecular weight marker market can be divided into PCR, sequencing,, northern blotting,, southern blotting,, molecular cloning,, and others segments.
Product Definition:
A DNA molecular weight marker is a small piece of DNA that has been specifically designed to have a well-known and easily measured molecular weight. This makes it ideal for use as a calibration tool in gel electrophoresis experiments, allowing researchers to accurately determine the size of other pieces of DNA.
Below 50 base-pair (bp):
Below 50 bp is the size range of DNA that can be detected by electrophoresis in an agarose gel. It's used as a molecular weight marker for DNA and RNA samples in research and development studies. The molecular weight of DNA or RNA is an important factor to consider when conducting genetic experiments on them.
The size (size) of a particular nucleic acid depends on its structure, sequence,.
50 bp to 100 bp:
The molecular weight of DNA is dependent on the size of its sugar-phosphate backbone. The higher the number, the larger and heavier will be DNA molecule.
Molecular Weight (MW) is an important parameter used in determining genetic sequence as well as protein structure.
Application Insights:
Molecular cloning accounted for the largest revenue share in 2015 and is anticipated to continue its dominance over the forecast period. This can be attributed to its high specificity for amplifying DNA targets. The advent of polymerase chain reaction (PCR) has revolutionized molecular biology research, especially in the field of genetic engineering and human health diagnostics. Extensive R&D by various companies including Thermo Fisher Scientific, Inc., Applied Biosystems, Inc., and others are contributing toward segment growth.
DNA sequencing is expected to witness lucrative growth during the forecast period owing to increasing demand from diagnostic laboratories across the world seeking information regarding patients¢â‚¬â„¢ disease susceptibility genes as well as other related information such as diseases associated with particular ethnicities or geographical locations etc.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of sequencing, molecular-genetic and PCR laboratories in this region. The U.S., which is considered as one of the most developed countries, holds a major share in this regional market owing to high demand for advanced diagnostic techniques coupled with rising healthcare expenditure by patients and insurance providers.
Asia Pacific is expected to grow at an exponential rate during the forecast period due to increasing R&D investments by pharmaceutical companies as well as government support for higher education sector resulting into better healthcare facilities throughout this region eventually driving up demand for molecular weight markers used during DNA analysis procedures over the next eight years.
Growth Factors:
- Increasing demand for DNA molecular weight markers in the life sciences sector for research and development purposes.
- Rising prevalence of genetic disorders and cancer, which is expected to drive the demand for DNA molecular weight markers over the forecast period.
- Technological advancements in DNA sequencing and polymerase chain reaction (PCR) techniques that would require use of DNA molecular weight markers, thereby propelling market growth.
- Growing number of contract research organizations (CROs) and pharmaceutical companies that are outsourcing their R&D activities, which is anticipated to create lucrative opportunities for the market players over the next few years
Scope Of The Report
Report Attributes
Report Details
Report Title
DNA Molecular Weight Marker Market Research Report
By Type
Below 50 base-pair (bp), 50 bp to 100 bp, 100 bp to 1 kilo base-pair (kb), 1 kb to 5 kb, Above 5 kb
By Application
PCR, Sequencing, Northern Blotting, Southern Blotting, Molecular cloning, Others
By Companies
F Hoffmann-La Roche AG (Switzerland), Thermo Fisher Scientific Inc. (US), Agilent Technologies (US), Sigma-Aldrich (US), Affymetrix, Inc.(US), QIAGEN (Netherlands), Takara Bio Inc. (Japan), Bio-Rad Laboratories (US), Promega Corporation (US), New England Biolabs (US), F Hoffmann-La Roche AG (Switzerland)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global DNA Molecular Weight Marker Market Report Segments:
The global DNA Molecular Weight Marker market is segmented on the basis of:
Types
Below 50 base-pair (bp), 50 bp to 100 bp, 100 bp to 1 kilo base-pair (kb), 1 kb to 5 kb, Above 5 kb
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
PCR, Sequencing, Northern Blotting, Southern Blotting, Molecular cloning, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- F Hoffmann-La Roche AG (Switzerland)
- Thermo Fisher Scientific Inc. (US)
- Agilent Technologies (US)
- Sigma-Aldrich (US)
- Affymetrix, Inc.(US)
- QIAGEN (Netherlands)
- Takara Bio Inc. (Japan)
- Bio-Rad Laboratories (US)
- Promega Corporation (US)
- New England Biolabs (US)
- F Hoffmann-La Roche AG (Switzerland)
Highlights of The DNA Molecular Weight Marker Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Below 50 base-pair (bp)
- 50 bp to 100 bp
- 100 bp to 1 kilo base-pair (kb)
- 1 kb to 5 kb
- Above 5 kb
- By Application:
- PCR
- Sequencing
- Northern Blotting
- Southern Blotting
- Molecular cloning
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the DNA Molecular Weight Marker Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
DNA molecular weight marker is a specific type of DNA sequence that can be used to determine the size of a DNA molecule.
Some of the major players in the dna molecular weight marker market are F Hoffmann-La Roche AG (Switzerland), Thermo Fisher Scientific Inc. (US), Agilent Technologies (US), Sigma-Aldrich (US), Affymetrix, Inc.(US), QIAGEN (Netherlands), Takara Bio Inc. (Japan), Bio-Rad Laboratories (US), Promega Corporation (US), New England Biolabs (US), F Hoffmann-La Roche AG (Switzerland).
The dna molecular weight marker market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 DNA Molecular Weight Marker Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 DNA Molecular Weight Marker Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 DNA Molecular Weight Marker Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the DNA Molecular Weight Marker Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global DNA Molecular Weight Marker Market Size & Forecast, 2020-2028
4.5.1 DNA Molecular Weight Marker Market Size and Y-o-Y Growth
4.5.2 DNA Molecular Weight Marker Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Below 50 base-pair (bp)
5.2.2 50 bp to 100 bp
5.2.3 100 bp to 1 kilo base-pair (kb)
5.2.4 1 kb to 5 kb
5.2.5 Above 5 kb
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 PCR
6.2.2 Sequencing
6.2.3 Northern Blotting
6.2.4 Southern Blotting
6.2.5 Molecular cloning
6.2.6 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global DNA Molecular Weight Marker Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 DNA Molecular Weight Marker Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Below 50 base-pair (bp)
9.6.2 50 bp to 100 bp
9.6.3 100 bp to 1 kilo base-pair (kb)
9.6.4 1 kb to 5 kb
9.6.5 Above 5 kb
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 PCR
9.10.2 Sequencing
9.10.3 Northern Blotting
9.10.4 Southern Blotting
9.10.5 Molecular cloning
9.10.6 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Below 50 base-pair (bp)
10.6.2 50 bp to 100 bp
10.6.3 100 bp to 1 kilo base-pair (kb)
10.6.4 1 kb to 5 kb
10.6.5 Above 5 kb
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 PCR
10.10.2 Sequencing
10.10.3 Northern Blotting
10.10.4 Southern Blotting
10.10.5 Molecular cloning
10.10.6 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Below 50 base-pair (bp)
11.6.2 50 bp to 100 bp
11.6.3 100 bp to 1 kilo base-pair (kb)
11.6.4 1 kb to 5 kb
11.6.5 Above 5 kb
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 PCR
11.10.2 Sequencing
11.10.3 Northern Blotting
11.10.4 Southern Blotting
11.10.5 Molecular cloning
11.10.6 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Below 50 base-pair (bp)
12.6.2 50 bp to 100 bp
12.6.3 100 bp to 1 kilo base-pair (kb)
12.6.4 1 kb to 5 kb
12.6.5 Above 5 kb
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 PCR
12.10.2 Sequencing
12.10.3 Northern Blotting
12.10.4 Southern Blotting
12.10.5 Molecular cloning
12.10.6 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Below 50 base-pair (bp)
13.6.2 50 bp to 100 bp
13.6.3 100 bp to 1 kilo base-pair (kb)
13.6.4 1 kb to 5 kb
13.6.5 Above 5 kb
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 PCR
13.10.2 Sequencing
13.10.3 Northern Blotting
13.10.4 Southern Blotting
13.10.5 Molecular cloning
13.10.6 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 DNA Molecular Weight Marker Market: Competitive Dashboard
14.2 Global DNA Molecular Weight Marker Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 F Hoffmann-La Roche AG (Switzerland)
14.3.2 Thermo Fisher Scientific Inc. (US)
14.3.3 Agilent Technologies (US)
14.3.4 Sigma-Aldrich (US)
14.3.5 Affymetrix, Inc.(US)
14.3.6 QIAGEN (Netherlands)
14.3.7 Takara Bio Inc. (Japan)
14.3.8 Bio-Rad Laboratories (US)
14.3.9 Promega Corporation (US)
14.3.10 New England Biolabs (US)
14.3.11 F Hoffmann-La Roche AG (Switzerland)
